We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01255098
First Posted: December 7, 2010
Last Update Posted: December 7, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Taipei Medical University WanFang Hospital
  Purpose
This plan is to develop blood culture or to measure diagnostics of Immuno Magnetic Reduction assay in the first stage.

Condition
Immuno Magnetic Reduction

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: A Development Plan of in Vitro Diagnostics of Immuno Magnetic Reduction Assay - A Rapid Etection Kit of Enterobacteraceae in Blood or Blood Culture

Further study details as provided by Taipei Medical University WanFang Hospital:

Enrollment: 300
Study Start Date: November 2009
Study Completion Date: November 2010
Groups/Cohorts
Experimental Group
Control Group

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
emergency cases
Criteria

Inclusion Criteria:

  • emergency cases
  • blood culture of positive and negative cases which storage in 4℃ every day

Exclusion Criteria:

  • not emergency cases of blood culture
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01255098


Locations
Taiwan
Taipei Medical University WanFang Hospital
Taipei, Taiwan
Sponsors and Collaborators
Taipei Medical University WanFang Hospital
Investigators
Principal Investigator: Giueng-Chueng Wang Taipei Medical University WanFang Hospital
  More Information

Responsible Party: Giueng-Chueng Wang, Laboratory Medicine
ClinicalTrials.gov Identifier: NCT01255098     History of Changes
Other Study ID Numbers: 98085
First Submitted: December 3, 2010
First Posted: December 7, 2010
Last Update Posted: December 7, 2010
Last Verified: December 2010